Biotech | May 11, 2022
New nirsevimab data analyses reinforce efficacy against RSV
Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose
Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose
Omega plans to further strengthen its capabilities, deepen domain expertise and build new solutions
The plan is to advance innovative therapies to drug-resistant cancers
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year
In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
The report has estimated 4.74 million deaths for India in 2020 and 2021,
The facility is among 12 centres established worldwide, and the first in Asia
Subscribe To Our Newsletter & Stay Updated
